title: Immunosuppressory mini-regions of HLA-DP and HLA-DR.
abstract: Our previous studies showed, that the,TPQRGDVYT, QRGDVYT and RGDVYT fragments, located in the beta164-172 loop of HLA-DQ, strongly suppress the humoral and cellular immune response, while their shorter analogs, RGDV, RGDVY, and QRGDVY, show only weak stimulatory activity in respect to humoral immunological response. The fragments contain the RGDVY sequence that is analogous to thymopentin (pentapeptide RKDVY, an immune system activator) as well as the RGD sequence, known for its importance for cellular association phenomena. Based on the crystal structure of HLA-DR1, we also designed and synthesized a cyclic analog C*RGDVYC* (where C* indicates Cys participating in disulfide bridge) with restricted conformation, which strongly suppresses both humoral and cellular immune response. In the present study we synthesized and tested the immunological properties of the linear and cyclic HLA-DP and HLA-DR counterparts of all the above HLA-DQ fragments. Although the results show that the linear HLA-DP fragments possess moderate immunosuppressory potency, their conformationally restricted analog, C*QGDVYC*C shows a considerable suppression of both humoral and cellular immune response. The nonapeptide fragment of HLA-DR, VPRSGEVYT and particularly its cyclic analog C*SGEVYC*, are strong suppressors of the humoral response.
authors.affiliation: Faculty of Chemistry, University of Wroclaw, Poland. scewczuk@wchuwr.chem.uni.wroc.pl
authors.forename: Z
authors.initials: Z
authors.lastname: Szewczuk
authors.forename: A
authors.initials: A
authors.lastname: Wilczyński
authors.forename: P
authors.initials: P
authors.lastname: Stefanowicz
authors.forename: W
authors.initials: W
authors.lastname: Fedorowicz
authors.forename: I Z
authors.initials: IZ
authors.lastname: Siemion
authors.forename: Z
authors.initials: Z
authors.lastname: Wieczorek
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D000917:Antibody Formation; D002942:Circular Dichroism; D006682:HLA-DP Antigens / Q000737:chemistry* / Q000235:genetics; D006684:HLA-DR Antigens / Q000737:chemistry* / Q000235:genetics; D006462:Hemolytic Plaque Technique; D006801:Humans; D007108:Immune Tolerance; D007111:Immunity, Cellular; D007166:Immunosuppressive Agents / Q000737:chemistry / Q000276:immunology / Q000494:pharmacology; D051379:Mice; D008808:Mice, Inbred CBA; D010446:Peptide Fragments / Q000737:chemistry / Q000276:immunology / Q000494:pharmacology; D011487:Protein Conformation
chemical_list: D006682:HLA-DP Antigens; D006684:HLA-DR Antigens; D007166:Immunosuppressive Agents; D010446:Peptide Fragments